https://www.selleckchem.com/pr....oducts/lanifibranor-
lts from this exploratory analysis suggest that patients with sustained SAC not receiving concomitant heparin may benefit from ART-123, a fact that should be confirmed in future studies with more restrictive inclusion criteria. Results from this exploratory analysis suggest that patients with sustained SAC not receiving concomitant heparin may benefit from ART-123, a fact that should be confirmed in future studies with more restrictive inclusion criteria. As the elderly represent a substantial proportion of medical care ben
Like
Comment
Share
